- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Supriya Lifescience Ltd (SPRL)
Supriya Lifescience Ltd stock price live, this page displays NSE SPRL stock exchange data. View the SPRL premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Supriya Lifescience Ltd real time stock price chart below.
What Is the Supriya Lifescience Ltd Stock Price Today?
The Supriya Lifescience Ltd stock price today is 901.75.
What Is the Stock Symbol for Supriya Lifescience Ltd?
The stock symbol for Supriya Lifescience Ltd is "SPRL."
What Stock Exchange Does Supriya Lifescience Ltd Trade On?
Supriya Lifescience Ltd is listed and trades on the NSE stock exchange.
Is Supriya Lifescience Ltd a Good Stock to Buy?
Determining whether Supriya Lifescience Ltd, or any stock, is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the SPRL quote. (ISIN: INE07RO01027)
What Is the Supriya Lifescience Ltd Stock Price Today?
The Supriya Lifescience Ltd stock price today is 901.75.
What Is the Stock Symbol for Supriya Lifescience Ltd?
The stock symbol for Supriya Lifescience Ltd is "SPRL."
What Stock Exchange Does Supriya Lifescience Ltd Trade On?
Supriya Lifescience Ltd is listed and trades on the NSE stock exchange.
Is Supriya Lifescience Ltd a Good Stock to Buy?
Determining whether Supriya Lifescience Ltd, or any stock, is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the SPRL quote. (ISIN: INE07RO01027)
901.75
-15.70(-1.71%)
Closed·
Fair Value
An estimate of a Supriya Lifescience's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
891.25
915.30
52 wk Range
545.50
1,085.00
SPRL is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a Supriya Lifescience's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
891.25915.30
52 wk Range
545.501,085.00
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(0.11%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(0.11%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
SPRL Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Supriya Lifescience's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Strong Buy
Price Target
940.00
Upside
+4.24%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Prominent player in the Pharmaceuticals industry
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Sell
Technical Indicators
Strong Sell
Moving Averages
Neutral
Analyst Ratings
2 Buy
0 Hold
0 Sell
Ratings:
2 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 940.00
(+4.24% Upside)
Earnings
Latest Release
Aug 13, 2026
EPS / Forecast
3.00 / --
Revenue / Forecast
1.9B / --
Compare SPRL to Peers and Sector
Metrics to compare | SPRL | Peers Peers - average of corresponding metrics from companies closely matching SPRL: CAPLIPOINT, GRANULES, SHILPAMED, MOREPENLAB, ACUTAAS | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipSPRLPeersSector |
|---|---|---|---|---|
P/E Ratio | 36.6x | 38.1x | −0.4x | |
PEG Ratio | 3.21 | 0.89 | 0.00 | |
Price/Book | 6.1x | 5.1x | 2.6x | |
Price / LTM Sales | 8.3x | 4.0x | 3.0x | |
Upside (Analyst Target) | 4.2% | 0.4% | 55.1% | |
Fair Value Upside | Unlock | −5.3% | 8.2% | Unlock |
Supriya Lifescience Limited engages in the research and development, manufacture, and sale of bulk drugs and pharmaceutical chemicals in India and internationally. The company offers active pharmaceuticals ingredients in antihistamine, anti-allergic, anti-asthmatic, decongestant, analgesic/anti-pyretic/anesthetic, anti–hypertensive, vitamins, anti-malarial, and anti-gout areas. It also provides finished formulation products. In addition, the company offers GelHeal, a wound care solution; and Quickblue, an oral cancer detection kit. Further, it develops drugs in the areas of anti-depressant, anti-inflammatory, contrast media, hormones, antibiotic, smoking cessation, anti-diabetic/obesity, anti-ataxia, decongestant, veterinary API, anti-cancer, allogeneic hematopoietic stem cell transplantation, and anti-migraine. Supriya Lifescience Limited was founded in 1987 and is headquartered in Mumbai, India.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Supriya Lifescience (SPRL) Stock Price Today?
The Supriya Lifescience stock price today is 901.75 INR.
What Stock Exchange Does Supriya Lifescience Trade On?
Supriya Lifescience is listed and trades on the India National Stock Exchange.
What Is the Stock Symbol for Supriya Lifescience?
The stock symbol for Supriya Lifescience is "SPRL."
What Is the Supriya Lifescience Market Cap?
As of today, Supriya Lifescience market cap is 72.58B INR.
When Is the Next Supriya Lifescience Earnings Date?
Supriya Lifescience will release its next earnings report on Nov 11, 2026.
From a Technical Analysis Perspective, Is SPRL a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Supriya Lifescience Stock Split?
Supriya Lifescience has split 0 times.
How Many Employees Does Supriya Lifescience Have?
Supriya Lifescience has 607 employees.
What is the current trading status of Supriya Lifescience (SPRL)?
As of Sep 13, 2026, Supriya Lifescience (SPRL) is trading at a price of 901.75 INR, with a previous close of 917.45 INR. The stock has fluctuated within a day range of 891.25 INR to 915.30 INR, while its 52-week range spans from 545.50 INR to 1,085.00 INR.
What Is Supriya Lifescience (SPRL) Price Target According to Analysts?
The average 12-month price target for Supriya Lifescience is 940.00 INR, with a high estimate of 1030 INR and a low estimate of 850 INR. 2 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +4.24% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2026 - Fusion Media Limited. All Rights Reserved.